126 related articles for article (PubMed ID: 10611194)
1. Clinical presentation of PCOS following development of an insulinoma: case report.
Murray RD; Davison RM; Russell RC; Conway GS
Hum Reprod; 2000 Jan; 15(1):86-8. PubMed ID: 10611194
[TBL] [Abstract][Full Text] [Related]
2. Insulinoma presenting with hyperandrogenism: a case report and a literature review.
Stanciu IN; Pitale S; Prinz RA; Jakate S; Webb G; Steiner D; Braithwaite S; Gordon D; Emanuele MA
J Intern Med; 2003 Apr; 253(4):484-9. PubMed ID: 12653879
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.
Adams J; Polson DW; Franks S
Br Med J (Clin Res Ed); 1986 Aug; 293(6543):355-9. PubMed ID: 3089520
[TBL] [Abstract][Full Text] [Related]
4. Spuriously high androstendione concentrations due to assay interference as a cause of diagnostic conundrum in women with oligomenorrhoea.
Lewandowski KC; Grotowski W; Dabrowska K; Głowacka E; Lewiński A
Ginekol Pol; 2015 Mar; 86(3):229-33. PubMed ID: 25920315
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.
Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R
J Clin Endocrinol Metab; 2007 Jun; 92(6):2066-73. PubMed ID: 17356050
[TBL] [Abstract][Full Text] [Related]
6. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Barber TM; Wass JA; McCarthy MI; Franks S
Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
[TBL] [Abstract][Full Text] [Related]
7. Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound.
Carmina E; Wong L; Chang L; Paulson RJ; Sauer MV; Stanczyk FZ; Lobo RA
Hum Reprod; 1997 May; 12(5):905-9. PubMed ID: 9194637
[TBL] [Abstract][Full Text] [Related]
8. Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries.
Franks S; Webber LJ; Goh M; Valentine A; White DM; Conway GS; Wiltshire S; McCarthy MI
J Clin Endocrinol Metab; 2008 Sep; 93(9):3396-402. PubMed ID: 18559912
[TBL] [Abstract][Full Text] [Related]
9. Clinical expression of polycystic ovary syndrome in adolescent girls.
Sultan C; Paris F
Fertil Steril; 2006 Jul; 86 Suppl 1():S6. PubMed ID: 16798287
[TBL] [Abstract][Full Text] [Related]
10. The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS).
Lewandowski KC; Cajdler-Łuba A; Salata I; Bieńkiewicz M; Lewiński A
Endokrynol Pol; 2011; 62(2):120-8. PubMed ID: 21528473
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the correlation between insulin like factor 3, polycystic ovary syndrome, and ovarian maldescent.
Seyam E; Hefzy E
Gynecol Endocrinol; 2018 Jun; 34(6):481-488. PubMed ID: 29254383
[TBL] [Abstract][Full Text] [Related]
12. [Missed hyperinsulinaemia in a patient with an insulinoma].
Wouters RS; van den Ouweland JM; Pouwels JG; Wolffenbuttel BH
Ned Tijdschr Geneeskd; 2005 Apr; 149(17):944-6. PubMed ID: 15884409
[TBL] [Abstract][Full Text] [Related]
13. Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography-tandem mass spectrometry and analysis by receiver operator characteristic plots.
Barth JH; Field HP; Yasmin E; Balen AH
Eur J Endocrinol; 2010 Mar; 162(3):611-5. PubMed ID: 20008514
[TBL] [Abstract][Full Text] [Related]
14. Endocrine features of polycystic ovary syndrome in a random population sample of 14-16 year old adolescents.
van Hooff MH; Voorhorst FJ; Kaptein MB; Hirasing RA; Koppenaal C; Schoemaker J
Hum Reprod; 1999 Sep; 14(9):2223-9. PubMed ID: 10469684
[TBL] [Abstract][Full Text] [Related]
15. Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?
Catteau-Jonard S; Bancquart J; Poncelet E; Lefebvre-Maunoury C; Robin G; Dewailly D
Ultrasound Obstet Gynecol; 2012 Aug; 40(2):223-9. PubMed ID: 22648908
[TBL] [Abstract][Full Text] [Related]
16. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
van der Westhuizen S; van der Spuy ZM
Ultrasound Obstet Gynecol; 1996 May; 7(5):335-41. PubMed ID: 8774098
[TBL] [Abstract][Full Text] [Related]
17. Clinical and metabolic characteristics of Turkish adolescents with polycystic ovary syndrome.
Ates S; Aydın S; Ozcan P; Soyman Z; Gokmen Karasu AF; Sevket O
J Obstet Gynaecol; 2018 Feb; 38(2):236-240. PubMed ID: 28920502
[TBL] [Abstract][Full Text] [Related]
18. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
19. [Ovarian hyperandrogenism in adolescent girls with menstrual disorders].
Małecka-Tendera E; Zachurzok A; Wrześniewski N; Kurkowska M
Ginekol Pol; 2002 Feb; 73(2):93-101. PubMed ID: 12001778
[TBL] [Abstract][Full Text] [Related]
20. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
